Olysio and Fainting - a phase IV clinical study of FDA data

Summary:

Fainting is reported as a side effect among people who take Olysio (simeprevir), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Sovaldi, and have Hepatitis c.

The phase IV clinical study analyzes which people have Fainting when taking Olysio. It is created by eHealthMe based on reports of 3,074 people who have side effects when taking Olysio from the FDA, and is updated regularly.

What is Olysio?

Olysio has active ingredients of simeprevir. eHealthMe is studying from 3,076 Olysio users. Check the latest studies of Olysio.

What is Fainting?

Fainting (loss of consciousness and postural tone) is found to be associated with 2,456 drugs and 3,547 conditions by eHealthMe. Check the latest studies of Fainting.

On Jul, 11, 2026

3,074 people reported to have side effects when taking Olysio.
Among them, 22 people (0.72%) have Fainting.

Among these 22 people:

How long have people been on Olysio when they have Fainting? *

What is the gender of people who have Fainting when taking Olysio? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Fainting when taking Olysio? *

What are other drugs people take besides Olysio? *

What are other side effects people have besides Fainting? *

Hypotension (abnormally low blood pressure): 11 people, 50.00%
Dizziness: 10 people, 45.45%
Sinus Bradycardia (an unusually slow heartbeat due to heart disease): 5 people, 22.73%
Nausea And Vomiting: 4 people, 18.18%
Sinoatrial Block: 4 people, 18.18%
Headache (pain in head): 3 people, 13.64%
Dry Skin: 3 people, 13.64%
Weakness: 3 people, 13.64%
Fatigue (feeling of tiredness): 3 people, 13.64%
Nausea (feeling of having an urge to vomit): 3 people, 13.64%

What are the existing conditions these people have? *

Hepatitis C: 11 people, 50.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 22.73%
Hepatitis C Virus Test Positive: 3 people, 13.64%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 9.09%
Diabetes: 2 people, 9.09%
Stress And Anxiety: 1 person, 4.55%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.55%
High Blood Pressure: 1 person, 4.55%
Headache (pain in head): 1 person, 4.55%
Cardiac Disorder: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Olysio and have Fainting?

- Check whether Fainting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Olysio:

Olysio (3,076 reports)

Fainting treatments and more:

Fainting (131,321 reports)

Browse all side effects of Olysio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fainting:

Fainting (2,456 drugs)

Browse all the conditions that are associated with Fainting:

Fainting (3,547 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on simeprevir (the active ingredients of Olysio) and Olysio (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.